Archive for the ‘Buffalo’ Category

Kinex Phrarmaceuticals (Buffalo) Receives Therapeutic Discovery Grant (12/8/2010)

December 13, 2010

Kinex Pharmaceuticals develops and commercializes therapies for cancer and immunomodulatory diseases. The company’s technology is based on work performed by University at Buffalo Chemistry Professor David Hangauer, who serves as Senior Vice President, Research and Development.

From the company’s press release:
Kinex Pharmaceuticals has been awarded a grant from the Qualifying Therapeutic Discovery Project tax credit program which is provided under new section 48D of the Internal Revenue Code (IRC) enacted as part of the Patient Protection and Affordable Care Act of 2010. read full press release